Archive - March 2020
Towards a Multichannel Marketing Culture
Doctors worried NHS is unprepared for coronavirus as government unveils action plan
Keytruda improves PFS in classical Hodgkin lymphoma
Gilead strikes $4.9bn deal to buy Forty Seven
GW Pharma regains Sativex rights in UK
FDA approves Sanofi’s key cancer drug Sarclisa for myeloma
EMA PRIME status granted to Janssen’s inherited retinal disease gene therapy
Sandoz admits antitrust crime, pays $195m in penalties